
    
      Main: To demonstrate the bioequivalence between the two transdermal analgesic formulations
      after single patch application. Pharmacokinetic target parameters are AUC, AUC0-t, and Cmax.

      Further: To assess the safety, tolerability, skin tolerability and adhesiveness of the patch
      applications.
    
  